Laboratory Test DirectoryShare
H. Pylori (Helicobacter Pylori) Urea Breath Test
Accu Reference Medical Lab now offers H.Pylori Breath Test using BreathID®Hp Breath Test System, the latest 13C-Urea breath test (UBT) technology for the accurate detection of H. pylori bacteria.
The Urea Breath Test (UBT) is recommended by both the American GastroenterologicalAssociation (AGA) and the American College of Gastroenterology (ACG) as a non-invasive test for diagnosis and conformation of eradication.1,2
|Methodology:||Analysis of pre- and postbreath samples to detect 13CO2|
Collect: Breath samples pre- and postingestion of fruit-flavored powder solution, containing 13C-urea diagnostic component from adults only.
Container: One blue sample bag labeled “baseline” and one "postdose" (pink or gray) sample bag (BreathID®Hp)
Patient Preparation: The patient should fast for at least one hour prior to testing. The patient should not take antimicrobials, proton pump inhibitors, or bismuth preparations within two weeks prior to testing. Note: Solution contains phenylalanine. Phenylketonurics should be warned.
- Blue sample bag (baseline) must be collected as follows:
• Remove the blue breath collection bag from the kit.
• Remove the pulloff cap from mouthpiece of the breath collection bag.
• Instruct the patient to breathe normally, then take a deep breath, pause holding their breath for a full second (counting one, one thousand) then exhale into the mouthpiece of the bag.
• Replace the cap in the mouth piece of the bag. Prepare the fruit-flavored powder solution, containing 13C-urea diagnostic component as detailed in the kit instructions Postdose sample bag (pink or gray) is collected as follows:
• Instruct the patient to drink all the solution without “rinsing” mouth before swallowing.
• Have the patient sit quietly for 15 minutes. Set timer for 15 minutes.
• After 15 minutes, collect the pink or gray sample bag as outlined for the baseline specimen above.
All sample bags must be labeled .
Causes for Rejection: Prolonged transport more than seven days; specimens collected from persons younger than 18 years of age.
Storage/Transport Temperature: Room Temperature
Stability: Room Temperature : 7 days
NOTE: * This test is not available for New York patients, please refer to test code T371 for specimen requirements.*
Lincoln Diagnostics LLC
A non-invasive, non-radioactive breath test for effective, proactive H. pylori management to:
- Accurately detect active H. pylori infection using patient breath samples3,4
- Determine whether treatment for an H. pylori infection has been successful4
- Provide cost-effective testing relative to other diagnostic methods 4
Urea Breath Test provides the ability to confirm between active and resolved infections when compared to antibody testing3,4
- Minimizes false positive results since antibody testing cannot distinguish between current infection and recent exposure to infection 3,4,5
- Accuracy of blood antibody tests differs based on geography and varying local H. pylori strains 5
- Reduces the number of patients inappropriately treated 3
Due to its accuracy and convenience, 13C-UBT is recommended by both the American College of Gastroenterology (ACG) and American Gastroenterology Association (AGA), as well as by the American Academy of Family Physicians (AAFP) for both initial diagnosis of H. pylori and post-treatment follow-up testing to confirm eradication.
Most notably, testing to confirm eradication following treatment is an essential diagnostic step that is frequently not performed. Studies show that standard H. pylori therapy is successful in approximately 80% of patients, meaning 1 in 5 remain infected following treatment. Confirming the continued presence of H. pylori post-treatment can direct us down an alternative treatment pathway to ensure we reach eradication. Likewise, proving successful eradication can prevent the unnecessary prescription or over-the-counter use of PPIs or other acid reducing medications.Blood or serology tests are antibody-based and cannot be used post-treatment and UBT is the preferred diagnostic modality.
Individuals Suitable for Testing6
- Adults with symptomatic active peptic ulcer disease
- Adults with a history of documented peptic ulcer
- Adults with mucosal-associated-lymphoid-type (MALT) lymphoma
- Testing should be performed only when treatment is intended.
- Post-Therapeutic Testing
- All adult patients
1. Talley NJ; American Gastroenterological Association. American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology. 2005;129:1753-1755.
2. Talley NJ, Vakil N; Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the management of dyspepsia.
Am J Gastroenterol. 2005;100:2324-2337.
3. Vakil N, Fendrick AM. How to test for Helicobacter pylori in 2005. Cleve Clin J Med. 2005;72 Suppl 2:S8-S13.
4. Saad R, Chey W D. A clinician’s guide to managing Helicobacter pylori infection. Cleve Clin J Med. 2005;72:109-110, 112-113, 117-118.
5. Chey W D. Diagnosis of Helicobacter pylori. Pract Gastroenterol. April 2001;28-41.
6. Chey WD, Wong BCY; Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102:1808-1825
Also known as: H pylori; H-pylori; H. pylori antibody test; H. pylori stool antigen test; H. pylori breath test; Urea breath test; CLO test; Rapid urease test (RUT) for H. pylori, 13C Urea Breath Test, H. Pylori Urea Breath Test, Helicobactor Breath Test, Pylori, Ulcer Breath Test, Urea Breath Test.